A home for LASIK comments
This article was originally published in The Gray Sheet
Executive Summary
FDA establishes a dedicated docket for public comments on post-market experience with LASIK laser vision correction surgery, the agency announces Sept. 12. After updating its LASIK Web site and strengthening post-market surveillance activities, FDA says it wants to better understand post-treatment quality-of-life issues. LASIK complications have taken a high-profile in recent months, and on May 19 yet another citizen petition was filed urging FDA to ban the devices (1"The Gray Sheet" March 24, 2008, p. 6). Comments may be submitted to FDA-2008-N-0488 through Sept. 14, 2009